ROI for sustainability initiatives often come later as lower maintenance and utility costs. Bayer's pursuit of LEED certification led to substantial savings up front.
- What FDA Inspectors Want From Your OOS File
- You Can't CAPA What You Can't Classify
- New USP Guidelines, Standards Address Lentivirus Characterization
- Inside Kyverna's Autoimmune CAR T Platform Beyond SPS
- Bringing Next-Gen Sequencing To GMP Scale
- Risk Managing Through The Void Of ATMP Visible Particle Guidance
- Engineering CAR T Cells With mRNA-LNPs: Applying Oncology Learnings To Allergic Diseases
- The Promise Of MRD-Guided CAR-T Treatment
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1931925757-assay-well-plate-pipette-red-liquid]( "Flow Cytometric Analysis: Differentiation Potential Of Human Stem Cells")
Flow Cytometric Analysis: Differentiation Potential Of Human Stem CellsExplore an assay kit that simplifies handling with a methylcellulose-free medium and clear flow cytometric readout, which enhances automation and high-throughput sample acquisition for versatile research.
-
![Cydem VT]( "A High-Throughput Platform For Fast And Reliable Clone Screening")
A High-Throughput Platform For Fast And Reliable Clone ScreeningThe Cydem VT platform consists of several technologies allowing for the cultivation and monitoring of CHO cells in cell line development. Find out how to set up your experiment on this device.
-
![cell-therapy-GettyImages-1494029118]( "Redefining The Analytical Frameworks Surrounding Capsid Characterization")
Redefining The Analytical Frameworks Surrounding Capsid CharacterizationModern AAV manufacturing demands precise capsid characterization to distinguish empty, partial, and full particles, as regulators now require rigorous purity and potency control for clinical safety.
-
![Computer Science Research Laboratory with Robotic Arm Model-GettyImages-968289652]( "End-To-End Workflow Integration For Antibody Development")
End-To-End Workflow Integration For Antibody DevelopmentModern antibody discovery generates massive, fragmented datasets that slow collaboration and decision‑making. Examine how unified digital workflows streamline R&D and improve data quality.
-
![RNA, ribonucleic acid-GettyImages-2195556279]( "De-Risk Nucleic Acid Therapeutics Through Strategic Outsourcing")
De-Risk Nucleic Acid Therapeutics Through Strategic OutsourcingBringing a nucleic acid therapy to market requires specialized formulation and development knowledge. Innovators need rigorous analytical and formulation strategies to achieve stability and quality.
-
![Scientists working in lab-GettyImages-542935478]( "Cell Culture Media Mixing In A Benchtop Single-Use Mixer")
Cell Culture Media Mixing In A Benchtop Single-Use MixerExplore how efficient powder-liquid mixing and sterile filtration preserve media integrity and support reproducibility in biopharmaceutical workflows, with promising scalability for larger-volume applications.
-
![Bioreactor for cell culture-GettyImages-517653054]( "Chimeric Antigen Receptor Plasmid Production")
Chimeric Antigen Receptor Plasmid ProductionParallel single-use bioreactor setups enable faster optimization, improved reproducibility, and smoother transition from development to production—supporting more efficient and consistent cell therapy workflows.
-
![antibody molecules-GettyImages-2165626333]( "Evaluating Antibody Fragment Purification Using VH3 Resin")
Evaluating Antibody Fragment Purification Using VH3 ResinExplore how VH-domain targeting enables efficient purification of VH3 antibody fragments and bispecific formats, with strong recoveries and flexible wash conditions that support improved purity.
-
![GettyImages-2190246741 lab]( "Phase-Appropriate Approaches To Manufacturing And Testing")
Phase-Appropriate Approaches To Manufacturing And TestingAccelerate the development of high-quality biopharmaceuticals by implementing phase-appropriate, risk-based manufacturing and testing strategies that ensure timely progression.
-
![GettyImages-1590576166 cells, research, lab, assay]( "Stability Of Supplemented PRIME-XV T Cell CDM At Room Temperature")
Stability Of Supplemented PRIME-XV T Cell CDM At Room TemperatureGain insight into how a supplemented medium stored at room temperature for up to 72 hours maintained T cell expansion performance, showing consistent viability and marker expression.
NEWSLETTER ARCHIVE
- 09.23.26 -- Europe's ATMP Opportunity Still Requires Local Navigation
- 09.22.26 -- How Regeneron Navigates Early Cell And Gene Therapy Quality Risks
- 09.22.26 -- Balancing Innovation With Manufacturability When Designing Next Generation Vectors
- 09.21.26 -- CDMO Market Risk Report: Tracking Client M&A, Approvals, And FDA Rejections
- 09.18.26 -- Autoimmune CAR T Has Hit A Critical Moment. Are We Asking The Right Questions?
- Inside Kyverna's Autoimmune CAR T Platform Beyond SPS
- Autoimmune CAR T Has Hit A Critical Moment. Are We Asking The Right Questions?
- Why Celcuity's REVTORPYK Creates A New Path For Precision Oncology
- In Vivo CAR T Needs More Than Better Cell Engineering
- Reimagining Solid Tumor Immunotherapy With SRC-3-Edited Tregs
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
